Pregnancy Complications and Later Development of Hypertension

Suttira Intapad1, Barbara T Alexander

  • 1Department of Physiology and Biophysics and the Women's Health Research Center, University of Mississippi Medical Center, Jackson, MS, 39216.

Insights

Pregnancy complications like preeclampsia and diabetes can lead to maternal hypertension and future cardiovascular disease. These conditions may also program hypertension in offspring, highlighting the need for preventative research.

Area of Science:

  • Reproductive biology
  • Cardiovascular health
  • Developmental programming

Background:

  • Pregnancy complications, including preeclampsia and diabetes, affect 5-10% of pregnancies.
  • These conditions compromise maternal and fetal health, increasing risks for hypertension and cardiovascular disease later in life.
  • Fetal exposure to maternal hypertension/diabetes during gestation can program cardiovascular disease in offspring.

Purpose of the Study:

  • To investigate the mechanisms linking pregnancy complications to maternal hypertension.
  • To understand how these complications program cardiovascular risk in offspring.
  • To inform the development of preventative strategies for long-term maternal and child cardiovascular health.

Main Methods:

  • Experimental studies are needed to establish cause-and-effect relationships.
  • Research should focus on physiological changes in mothers and offspring following complicated pregnancies.
  • Longitudinal studies may be required to track cardiovascular outcomes across generations.

Main Results:

  • Experimental data is currently lacking to confirm the direct link between complicated pregnancies and maternal hypertension.
  • The transgenerational transmission of programmed cardiovascular risk requires further elucidation.
  • Specific mechanisms underlying fetal programming of hypertension remain to be identified.

Conclusions:

  • Complicated pregnancies pose significant risks for maternal and offspring cardiovascular health.
  • Further experimental research is crucial to understand these risks and develop effective interventions.
  • Addressing pregnancy complications is vital for improving long-term cardiovascular health across generations.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...